22nd Century Group Investor Relations Material
Latest events
Q1 2025
22nd Century Group
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from 22nd Century Group Inc
Access all reports
22nd Century Group Inc. is a biotechnology company focused on plant-based technology aimed at improving health and reducing harm in various industries. The company specializes in the genetic engineering of plants, with a primary focus on developing low-nicotine tobacco plants and hemp/cannabis plants with optimized cannabinoid profiles. 22nd Century Group’s technology is designed to support the development of products with reduced nicotine content for the tobacco industry and enhanced cannabinoids for the hemp and cannabis sectors. The company is headquartered in Buffalo, New York, and its shares are listed on the NASDAQ.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
XXII
Country
🇺🇸 United States